Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple MyelomaKevin R. Kelly, Steffan T. Nawrocki, Denice Tsao‐Wei et al.|Blood|2016Cited by 9